Diabetic Macular Edema
Introducing a Better Treatment Paradigm for Patients and Physicians
Navilas benefits for treatment of clinically significant macular edema have been evaluated in multiple studies world-wide.
These studies demonstrate a significant increase in accuracy, which in synergy with a more complete treatment has been basis for a faster onset of the treatment effect and an overall reduction in laser re-treatments.
Adding these benefits to anti-VEGF therapy has been shown to reduce the required number of injections while maintaining visual acuity gains achieved by the anti-VEGF treatments.